eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
3/2007
vol. 32
 
Share:
Share:
more
 
 
abstract:

Clinical immunology
318 C/T polymorphism of cytotoxic T lymphocyte antigen-4 in allegic asthma: functional analysis by gene ontology

Viroj Wiwanitkit

Centr Eur J Immunol 2007; 32 (3): 134-137
Online publish date: 2007/09/10
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Cytotoxic T lymphocyte antigen-4 (CTLA-4) represents one of the most extensively studied receptors in the costimulatory pathway and has recently been shown to function as a potent inhibitor of T cell-mediated immunity. The association of CTLA-4 gene polymorphisms with allergic asthma is still controversial and therefore was the subject of this study. However, the role of the CTLA-4 318 C/T change needs a systematic theoretical explanation. However, studies on an association between this polymorphism and clinical findings have yielded some inconsistent findings. To study the functional aberration in the human wild and mutate types of CTLA-4 in pathogenesis is hard. Here, the author used a new gene ontology technology to predict the molecular function of human wild and mutate types of CTLA-4. Here, it can be seen that there is no functional difference between wild and mutate types of CTLA-4. This can support the null effect of this polymorphism in clinical findings of the patients. This polymorphism might not be an important factor and have null effect on cardiovascular disease.
keywords:

CTLA-4, polymorphism, function

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.